GEMAYEL GEORGES

CIK 00012560889 companiesROCKVILLE, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001256088

Recent Transactions

50 trades

Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2026-03-06$25.30/sh+7,905→ 36,064 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2026-03-06$53.00/sh−8,787→ 27,277 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Director Stock Option (Right to Buy)
2026-03-06−7,905→ 0 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2026-03-05$53.71/sh−10,000→ 28,159 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2026-02-24−4,475→ 0 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2026-02-24+4,475→ 38,159 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2026-02-23$12.98/sh+15,000→ 33,684 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Director Stock Option (Right to Buy)
2026-02-23−15,000→ 0 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Director Stock Option (Right to Buy)
2026-02-18+4,977→ 4,977 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2026-02-18+2,989→ 2,989 total
Award
Disc Medicine, Inc.$IRON
Stock Option (Right to Buy)
2025-09-16+1,000→ 1,000 total
Award
Disc Medicine, Inc.$IRON
Stock Option (Right to Buy)
2025-06-11+10,000→ 10,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-02-22+5,369→ 18,684 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Units
2025-02-22−5,369→ 0 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2025-02-19+4,475→ 4,475 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Director Stock Option (Right to Buy)
2025-02-19+7,296→ 7,296 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-11-08$11.46/sh+10,787→ 24,102 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-11-08$36.30/sh−10,787→ 13,315 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Director Stock Option (Right to Buy)
2024-11-08−10,787→ 0 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-11-07$36.62/sh−14,213→ 13,315 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-11-07$11.46/sh+14,213→ 27,528 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Director Stock Option (Right to Buy)
2024-11-07−14,213→ 10,787 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-09-13$31.33/sh−10,000→ 13,315 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-09-13$11.46/sh+10,000→ 23,315 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-09-13$31.33/sh−3,886→ 13,315 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Director Stock Option (Right to Buy)
2024-09-13−10,000→ 25,000 total
Award
Disc Medicine, Inc.$IRON
Stock Option (Right to Buy)
2024-06-12+10,000→ 10,000 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2024-02-23−3,886→ 0 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-02-23+3,886→ 17,201 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Units
2024-02-22+5,369→ 5,369 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Director Stock Option (Right to Buy)
2024-02-22+8,252→ 8,252 total
Award
Disc Medicine, Inc.$IRON
Stock Option (Right to Buy)
2023-06-09+7,136→ 7,136 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Units
2023-02-23+3,886→ 3,886 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Director Stock Option (Right to Buy)
2023-02-23+6,293→ 6,293 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Units
2023-02-22−3,882→ 0 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2023-02-22+3,882→ 13,315 total
Award
Disc Medicine, Inc.$IRON
Stock Option (Right to Buy)
2022-12-29+7,000→ 7,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Units
2022-02-22+3,882→ 3,882 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Director Stock Option (Right to Buy)
2022-02-22+6,847→ 6,847 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Units
2022-02-19−4,222→ 0 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2022-02-19+4,222→ 9,433 total
Award
Disc Medicine, Inc.$IRON
Stock Option (Right to Buy)
2022-01-03+793,274→ 793,274 total
Award
Disc Medicine, Inc.$IRON
Stock Option (Right to Buy)
2021-11-15+17,245→ 17,245 total
Award
Disc Medicine, Inc.$IRON
Stock Option (Right to Buy)
2021-11-15+23,514→ 23,514 total
Award
Disc Medicine, Inc.$IRON
Stock Option (Right to Buy)
2021-04-29+45,466→ 45,466 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Director Stock Option (Right to Buy)
2021-02-19+7,365→ 7,365 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Units
2021-02-19+4,222→ 4,222 total
Disposition to Issuer
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy)
2020-10-01−11,207→ 0 total
Disposition to Issuer
MOMENTA PHARMACEUTICALS INC
Common Stock
2020-10-01−14,090→ 0 total
Disposition to Issuer
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy)
2020-10-01−8,855→ 0 total

Companies

Recent Filings

Address

C/O SUPERNUS PHARMACEUTICALS, INC., 9715 KEY WEST AVENUE

ROCKVILLE, MD, 20850

View on SEC.gov